La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Shanghai MicroPort Endovascular MedTech Performance dei guadagni passati
Il passato criteri di controllo 5/6
Shanghai MicroPort Endovascular MedTech has been growing earnings at an average annual rate of 28.4%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 30.1% per year. Shanghai MicroPort Endovascular MedTech's return on equity is 13.4%, and it has net margins of 43.8%.
Informazioni chiave
28.4%
Tasso di crescita degli utili
25.3%
Tasso di crescita dell'EPS
| Medical Equipment Crescita del settore | 16.0% |
| Tasso di crescita dei ricavi | 30.1% |
| Rendimento del capitale proprio | 13.4% |
| Margine netto | 43.8% |
| Prossimo aggiornamento sui guadagni | 27 Aug 2024 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends
Aug 15
Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel
Jun 29These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely
Apr 29Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem
Apr 09Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't
Mar 25Ripartizione dei ricavi e delle spese
Come Shanghai MicroPort Endovascular MedTech guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
| Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 31 Mar 24 | 1,260 | 552 | 190 | 160 |
| 31 Dec 23 | 1,187 | 492 | 187 | 173 |
| 30 Sep 23 | 1,121 | 444 | 193 | 167 |
| 30 Jun 23 | 1,059 | 421 | 191 | 161 |
| 31 Mar 23 | 924 | 358 | 160 | 139 |
| 31 Dec 22 | 897 | 357 | 153 | 138 |
| 30 Sep 22 | 839 | 367 | 125 | 123 |
| 30 Jun 22 | 781 | 346 | 117 | 114 |
| 31 Mar 22 | 745 | 338 | 113 | 115 |
| 31 Dec 21 | 685 | 316 | 105 | 102 |
| 30 Sep 21 | 652 | 302 | 97 | 99 |
| 30 Jun 21 | 618 | 279 | 92 | 91 |
| 31 Mar 21 | 569 | 257 | 90 | 85 |
| 31 Dec 20 | 470 | 215 | 79 | 73 |
| 30 Sep 20 | 414 | 192 | 76 | 61 |
| 30 Jun 20 | 377 | 177 | 72 | 53 |
| 31 Mar 20 | 341 | 156 | 71 | 51 |
| 31 Dec 19 | 334 | 142 | 71 | 50 |
| 30 Sep 19 | 306 | 127 | 65 | 42 |
| 30 Jun 19 | 282 | 115 | 60 | 37 |
| 31 Mar 19 | 257 | 103 | 66 | 37 |
| 31 Dec 18 | 231 | 91 | 53 | 30 |
| 31 Dec 17 | 165 | 63 | 32 | 20 |
| 31 Dec 16 | 125 | 41 | 28 | 20 |
Guadagni di qualità: 688016 has high quality earnings.
Margine di profitto in crescita: 688016's current net profit margins (43.8%) are higher than last year (38.8%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: 688016's earnings have grown significantly by 28.4% per year over the past 5 years.
Accelerare la crescita: 688016's earnings growth over the past year (54.1%) exceeds its 5-year average (28.4% per year).
Guadagni vs Settore: 688016 earnings growth over the past year (54.1%) exceeded the Medical Equipment industry 1.7%.
Rendimento del capitale proprio
ROE elevato: 688016's Return on Equity (13.4%) is considered low.